Home > Publications Database > Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment. > Access to Fulltext |
![]() |
|||||||
version 1 |
|
Restricted | ||||
![]() |
||||
version 1 |
|